期刊文献+

FoxQ1在食管鳞状细胞癌中的表达及其与预后 被引量:3

Expression and prognosis of FoxQ1 in esophageal squamous cell carcinoma
下载PDF
导出
摘要 目的:研究Fox Q1在食管鳞状细胞癌组织中的表达及其与临床病理特征和预后的关系。方法:在组织水平,应用免疫组织化学En Vision法检测91例食管鳞状细胞癌组织及相应癌旁组织Fox Q1的表达,并分析其表达与临床病理特征及预后之间的关系。结果:1)Fox Q1在食管鳞状细胞癌组织及配对正常食管组织中的阳性表达率分别为:62.6%(57/91)和23.1%(21/91),差异有统计学意义(P<0.05);Fox Q1的表达与肿瘤浸润深度、临床分期及预后相关(P<0.05)。经Kaplan-Meier法生存比较,Fox Q1的阳性表达者比阴性表达者生存期短(P<0.05);多因素Cox比例风险模型分析显示,Fox Q1可以作为判断食管鳞状细胞癌预后的独立因素(P<0.05)。结论:Fox Q1在食管鳞状细胞癌组织中高表达,其表达水平与食管鳞癌发生发展及预后密切相关。有望成为评估食管鳞状细胞癌预后的有效指标。 Objective:To investigate the expression of FoxQ1 in esophageal squamous cell carcinoma (ESCC) and analyze their clinical signiifcance, and to evaluate the correlation with prognosis. Methods:Immuno-histochemical method was used to detect the expression of FoxQ1 in 91 cases of ESCC tissues and adjacent normal esophageal tissues.χ2 test was used to analyze their correlations with the clinicopathologic factors and prognosis of ESCC patients. Results:hTe expression of FoxQ1 was signiifcantly higher in ESCC than that in normal esophageal tissues (62.6%vs 23.1%, P〈0.05). FoxQ1 expression had signiifcantly correlations with invasive depth, clinical stage and prognosis (P〈0.05). hTe results of Kaplan-Meier survival analysis indicated that positive expression of FoxQ1 were associated with a worse survival (P〈0.05). Conclusion:FoxQ1 was highly expressed in ESCC and signiifcantly correlated with prognosis of esophageal cancer;FOXQ1 might be an indicator to predict the prognosis in esophageal cancer.
出处 《临床与病理杂志》 CAS 2015年第9期1632-1636,共5页 Journal of Clinical and Pathological Research
关键词 食管鳞状细胞癌 FoxQ1 预后 esophageal squamous cell carcinoma FoxQ1 prognosis
  • 相关文献

同被引文献31

  • 1Solomon DA,Kim JS,Cronin JC, et al. Mutational in- activation of PTPRD in glioblastoma multiforme and malignant melanoma [J]. Cancer Res, 2008,68 (24) :10300-10306. 被引量:1
  • 2Cox,C,Bignell G,Greenman C,et al. A survey of ho- mozygous deletions in human cancer genomes [J]. Proc Natl Acad Sci USA, 2005,102 (12) : 4542-4547. 被引量:1
  • 3Sato M, Takahashi K, Nagayama K, et al. Identifica- tion of chromosome arm 9p as the most frequent tar- get of homozygous deletions in lung cancer[J]. Genes Chromosomes Cancer,2005,44(4) :405-414. 被引量:1
  • 4Stallings RL, Nair P, Marls JM, et al. High-resolution analysis of chromosomal breakpoints and genomic in- stability identifies PTPRD as a candidate tumor sup- pressor gene in neuroblastoma[J]. Cancer Res, 2006, 66(7) : 3673-3680. 被引量:1
  • 5Stark M, Hayward N. Genome-wide loss of heterozy- gosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays [J]. Cancer Res,2007,67(6) :2632-2642. 被引量:1
  • 6Purdie K J, Lambert SR, Teh MT, et al. Allelic imbal- ances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis [J]. Genes Chromosomes Cancer, 2007,46 (7) : 661- 669. 被引量:1
  • 7Nagayama K, Kohno T, Sato M, et al. Homozygous deletion scanning of the lung cancer genome at a 100- kb resolution[J]. Genes Chromosomes Cancer, 2007, 46(11) :1000-1010. 被引量:1
  • 8Weir BA, Woo MS,Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma[J]. Nature, 2007,450(7171) :893-898. 被引量:1
  • 9Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal canc- ers[J]. Science,2006,314(5797) :268-274. 被引量:1
  • 10Veeriah S, Brennan G, Meng S, et al. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers[J]. Proc Natt Acad Sci U S A,2009,106(23) :9435-9440. 被引量:1

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部